CHG-2022-0239

Analytical Method Change for Atezolimumab-R. Specification Change for Atezolimumab-R — minor update. Impacts 6 markets and 5 variations.

Change Number
CHG-2022-0239
Type
Analytical Method Change
Product
Atezolimumab-R
Status
Submitted
Owner
Dmitri Volkov
Initiated
2022-05-31
Description

Specification Change for Atezolimumab-R — minor update

Impacted Markets (6)
EU — European UnionCH — SwitzerlandDE — GermanyMX — MexicoTR — TurkeyBE — Belgium
Impacted Modules
2.3.P
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved